Item 7.01. Regulation FD Disclosure
On January 28, 2022, Maravai LifeSciences Holdings, Inc. announced that it has
acquired MyChem LLC, a San Diego, California-based provider of ultra-pure
nucleotides to customers in the diagnostics, pharma, genomics and research
markets. A copy of the press release announcing the acquisition is furnished as
Exhibit 99.1 to this Current Report on Form 8-K.
The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such
filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
The following exhibits are furnished as part of this Current Report on Form 8-K:

     Exhibit No.             Description of Exhibit
         99.1                  Press Release dated January 28, 2022
         104                 Cover Page Interactive Data File (embedded within the Inline XBRL
                             document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses